Literature DB >> 30520339

Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development.

K K Jagarlamudi1,2, L Wang1, S Eriksson1,2.   

Abstract

In this study changes in thymidine kinase 1 (TK1) levels after 24 hours of Doxorubicin (Dox) exposure of CEM and MDA MB-231 cells were determined using the commercially available AroCell TK 210 ELISA test. In cell extracts, TK1 levels increased twofold with 1 µM Dox in both cell lines, while the TK1 levels in the culture media increased with 5 and 10 µM of Dox only in case of CEM cells. In conclusion, this study reveals that the TK 210 ELISA can measure changes in intra- and extracellular TK1 levels apparently related to the mechanism of cytotoxicity of anti-cancer agents.

Entities:  

Keywords:  Doxorubicin; TK 210 ELISA; Thymidine kinase 1

Mesh:

Substances:

Year:  2018        PMID: 30520339     DOI: 10.1080/15257770.2018.1478094

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

1.  Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma.

Authors:  Johan Mattsson Ulfstedt; Per Venge; Sofia Holmgren; Gunilla Enblad; Staffan Eriksson; Daniel Molin
Journal:  Ups J Med Sci       Date:  2021-08-20       Impact factor: 2.384

2.  Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.

Authors:  K K Jagarlamudi; Swinkels L; Zupan M; Osredkar J; Venge P; Eriksson S
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.